Patents for C12P 21 - Preparation of peptides or proteins (112,499)
02/1999
02/25/1999WO1999009186A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999WO1999009182A2 Rab proteins
02/25/1999WO1999009177A2 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus
02/25/1999WO1999009176A1 Neisseria lactoferrin binding protein
02/25/1999WO1999009174A1 Genetic control of plant growth and development
02/25/1999WO1999009171A1 Ubc7-like ubiquitin-conjugating enzyme
02/25/1999WO1999009168A1 Testis-specific transcription factor zgcl-1
02/25/1999WO1999009166A2 Prostate tumor polynucleotide and antigen compositions
02/25/1999WO1999009165A1 Trail receptors, nucleic acids encoding the same, and methods of use thereof
02/25/1999WO1999009164A1 Coding sequence haplotypes of the human brca2 gene
02/25/1999WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999WO1999009159A1 Scavenger receptor-like proteins
02/25/1999WO1999009155A1 70 human secreted proteins
02/25/1999WO1999009146A1 Human serum inducible kinase (snk)
02/25/1999WO1999009140A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
02/25/1999WO1999009063A1 Interleukin-18 binding proteins, their preparation and use
02/25/1999WO1999009058A1 Isolated osteocalcin fragments
02/25/1999WO1999009049A1 Hypoxia-regulated genes
02/25/1999WO1999009046A1 Hypoxia-regulated genes
02/25/1999WO1999008708A2 Method and food product for increasing muscle protein and reducing fat in animals
02/25/1999WO1999008539A1 Novel phytase
02/25/1999WO1999008510A1 Atrial natriuretic factor mutants and ischemic stroke
02/25/1999WO1998046772A3 Gene conversion as a tool for the construction of recombinant industrial filamentous fungi
02/25/1999WO1998037418A3 Compounds for immunodiagnosis of prostate cancer and methods for their use
02/25/1999DE19837664A1 New antibodies against bi:cyclic pyrazine derivatives
02/25/1999DE19837391A1 Monoclonal antibody specific for dihydropyrimidine dehydrogenase
02/25/1999DE19735711A1 Insulin precursor
02/25/1999CA2301978A1 Gene coding for androctonine, vector containing same and transformed disease-resistant plants obtained
02/25/1999CA2301862A1 Atrial natriuretic factor mutants and ischemic stroke
02/25/1999CA2301801A1 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
02/25/1999CA2301796A1 70 human secreted proteins
02/25/1999CA2301374A1 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999CA2301332A1 Neisseria lactoferrin binding protein
02/25/1999CA2301202A1 Trail receptors, nucleic acids encoding the same, and methods of use thereof
02/25/1999CA2301043A1 Testis-specific transcription factor zgcl-1
02/25/1999CA2300918A1 Ubc7-like ubiquitin-conjugating enzyme
02/25/1999CA2300801A1 Rab proteins
02/25/1999CA2300476A1 Scavenger receptor-like proteins
02/25/1999CA2300364A1 Prostate tumor polynucleotide and antigen compositions
02/25/1999CA2300093A1 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999CA2299291A1 Method and food product for increasing muscle protein and reducing fat in animals
02/25/1999CA2298855A1 Interleukin-18 binding proteins, their preparation and use
02/25/1999CA2298540A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
02/25/1999CA2241430A1 Novel murb
02/25/1999CA2241403A1 Murb
02/25/1999CA2241392A1 Pigr-2, a member of immunoglobulin gene superfamily
02/25/1999CA2241390A1 Pigrl-1, a member of immunoglobulin gene superfamily
02/25/1999CA2239260A1 Human disintegrin metalloprotease related to drosophila kuz gene
02/24/1999EP0897988A1 Physiologically active substances tkr1785's, process for the preparation thereof, and microbe
02/24/1999EP0897987A2 Secretion of human protein linked to gamma interferon signal peptide
02/24/1999EP0897986A2 Aspartic proteinase 5 (ASP5)
02/24/1999EP0897983A2 Antibody against CD40-L
02/24/1999EP0897981A1 Pigr-1, a member of immunoglobulin gene superfamily
02/24/1999EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor
02/24/1999EP0897979A2 Human sdr2 cdna clone
02/24/1999EP0897541A1 Identification and isolation of novel polypeptides having ww domains and methods of using same
02/24/1999EP0897426A1 Matrix metalloprotease
02/24/1999EP0897424A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein
02/24/1999EP0897390A1 Human tumor necrosis factor delta and epsilon
02/24/1999EP0700440B1 Regulator of contact-mediated hemolysin
02/24/1999EP0439542B1 Filamentous hemagglutinin of b. pertussis
02/24/1999CN1209169A Process for microbial prodn. of amino acid by boosted activity of export carriers
02/24/1999CN1208731A Recombination human alpha type composite interferon, prepn. method and use therefor
02/23/1999US5874572 Process for preparing cyclosporin A
02/23/1999US5874562 Nucleic acid encoding developmentally-regulated endothelial cell locus-1
02/23/1999US5874561 DNA, host cell and vector encoding a protein with cytokine inhibitory activity
02/23/1999US5874560 Melanoma antigens and their use in diagnostic and therapeutic methods
02/23/1999US5874546 Genetically engineered protein having specific amino acid sequence
02/23/1999US5874544 Antibodies to APO(A)
02/23/1999US5874543 Platelet factor 4; antiinflammatory agent
02/23/1999US5874542 Single chain antibodies specific to VEGF receptors
02/23/1999US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site
02/23/1999US5874540 CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
02/23/1999US5874539 Antibodies to nuclear matrix proteins
02/23/1999US5874536 Proteins with Oncostatin M activity and process for their preparation
02/23/1999US5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
02/23/1999US5874533 HIV-2 envelope polypeptides
02/23/1999US5874527 Plasmodium vivax blood stage antigens
02/23/1999US5874526 Toxoplasma gondii antigens
02/23/1999US5874406 Synthetic peptide analogs of lung surface protein SP-C
02/23/1999US5874399 Progenitor B cell stimulating factor
02/23/1999US5874304 Humanized green fluorescent protein genes and methods
02/23/1999US5874300 Campylobacter jejuni antigens and methods for their production and use
02/23/1999US5874287 Mutagenized DNA molecules encoding modified subunit a of Cholera-toxin
02/23/1999US5874286 Tumor proteins
02/23/1999US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences
02/23/1999US5874267 Expression of surface layer proteins
02/23/1999US5874264 Retrovirus
02/23/1999US5874255 DNA encoding humanized antibodies specific for the ganglioside GM2
02/23/1999US5874253 Expression vectors and genetic engineering
02/23/1999US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor
02/23/1999US5874250 DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3
02/23/1999US5874245 Human G-protein coupled receptor (HIBCD07)
02/23/1999US5874243 OLRCC15 receptor
02/23/1999US5874236 DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits
02/23/1999US5874224 Growth factor receptor binding protein
02/23/1999US5874211 Chemokine expressed in eosinophils
02/23/1999US5874209 Regulation of transcription factor, NF-IL6/LAP
02/23/1999US5874083 Proteins and complexes for immune response
02/23/1999US5874081 Therapeutic compositions and methods for inhibition and treatment of tumor associated angiogenesis